ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO766

Effect Modification by Age and Pulse Pressure (PP) on the Association Between Mediterranean Diet (MD) and Telomere Length (TL) in Hemodialysis (HD) Patients

Session Information

Category: Dialysis

  • 601 Standard Hemodialysis for ESRD

Authors

  • Markaki, Anastasia, Technological Educational Institute of Crete, Greece, Siteia, Greece
  • Lygerou, Dimitra, University Hospital of Heraklion, Heraklion, Greece
  • Dermitzaki, Eleftheria-Kleio, University Hospital of Heraklion, Heraklion, Greece
  • Kyriazis, Periklis Panos, Beth israel Deaconess Medical Center, Brookline, Massachusetts, United States
  • Pilarinou, Andriana, Technological Educational Institute of Crete, Greece, Siteia, Greece
  • Gkouskou, Kalliopi K, Embiodiagnostics, Athens, Greece
  • Charonitaki, Aikaterini, Technological Educational Institute of Crete, Greece, Siteia, Greece
  • Kyriakidi, Konstantina, Technological Educational Institute of Crete, Greece, Siteia, Greece
  • Gioume, Argyro, Technological Educational Institute of Crete, Greece, Siteia, Greece
  • Bacharaki, Dimitra, ATTIKON UNIVERSITY HOSPITAL , Athens, Greece
  • Stylianou, Kostas, University Hospital of Heraklion, Heraklion, Greece
  • Vlahakos, Dimitrios V., None, Athens, Greece
Background

TL is considered to be a biological marker for aging. Telomere shortening is associated with age-related health outcomes and risk of death. Here, we investigated whether the associations of greater adherence to a MD with longer TL depend on age and pulse pressure in HD patients

Methods

46 HD patients, (28 men) were studied. A MD adherence score (MDS range 0-55, 55 representing maximal adherence) was estimated using a previously reported method (Panagiotakos 2007).TL was measured from leukocyte DNA using a realtime PCR to measure T/S ratio, the ratio of telomere (T) to single copy gene (S) sequence. TL was analyzed as a dichotomous variable: above (High TL group) and below (Low TL group) the median value of T/S ratio (1.13)

Results

Patients in the high TL group were younger in age (56±14 vs. 70±9 years; p<0.001), had higher MDS (30±4 vs. 28±3; P=0.037) and lower PP (58±14 vs.68±14 mmHg; p=0.02), prevalence of diabetes mellitus (DM)(8.7 vs. 34.8 %; p=0.032) and peripheral vascular disease (PVD) (30.4 vs. 65.2%; p=0.018). Logistic regression analysis, after adjusting for age, PP, DM and PVD, showed that MDS was associated with longer TL (OR=1.6, 95%CI: 1.13-2.28; p=0.009).An interaction effect between MDS and age was significant (p=0.014), after controlling for the main effects, CVD, DM and PP. The same was true for the interaction between MDS and PP (p=0.006). Stratifying by age (above and below the median= 65 years), we found a significant association between MDS and TL in the younger age group (OR=2.269, 95%CI: 1.021-5.042; p=0.044), but not in the older patients. Also, stratifying by PP tertiles (first <56 mmHg vs. second and third), a significant association between MDS and TL was detected in the high PP group (OR=1.49, 95%CI: 1.051-2.13; p=0.025). Similar results were obtained when TL was examined as a continuous variable.

Conclusion

Our results show that adherence to a MD is associated with longer TL in patients under the age of 65 and in patients with increased arterial stiffness (PP>56 mmHg), indicating that adoption of a MD may have beneficial effects in these specific subgroups of HD patients.

Funding

  • Clinical Revenue Support